# Epigenetic crosstalk in neuroblastoma development and progression

## TL;DR

This paper explores how epigenetic mechanisms influence the development and progression of neuroblastoma, a type of childhood cancer.

## Contribution

The study provides new insights into the interplay between developmental pathways and epigenetic control in neuroblastoma.

## Key findings

- Epigenetic crosstalk plays a key role in neuroblastoma differentiation and oncogenesis.
- Targeted therapies against epigenetic regulators show promise for improving patient outcomes.

## Abstract

Neuroblastoma (NB), a pediatric malignancy of the peripheral nervous system, accounts for 15% of pediatric cancer deaths and remains a major challenge for cancer therapy. NB originates from sympathoadrenal (SA) progenitors of the neural crest (NC) cell lineage, whose formation and differentiation are controlled by epigenetic mechanisms. Although signaling pathways and epigenetic factors implicated in NB tumorigenesis have been well-described, a holistic understanding of how development and epigenetics overlap to drive NB is lacking. By exploring vital interplays and co-dependencies between key pathways and their epigenetic control in NC development, we have gained novel insights into the mechanisms governing NB differentiation and oncogenesis. These converging insights have enabled the application of targeted therapies against epigenetic regulators driving NB with promising implications for patient outcomes.